PIPA

 A multicentre prospective cohort study of antibiotic allergy. The study commenced in 2015 at Austin Health, Peter MacCallum Cancer Centre and Alfred Health examining the impacts of antibiotic allergy testing on prescribing. Further, the study has ongoing recruitment of patients with severe delayed antibiotic hypersensitivities to collect blood for the development of novel diagnostics (IFN-y release Enzyme Linked ImmunoSpot Assay), immune profiling and pharmacogenomic assessment. 

Chief Investigator: A/Prof Jason Trubiano

Ethics approval date: 1st Apri 2015

Active sites: Austin Health and Peter MacCallum Cancer Centre (VIC, Australia)

Collaborating Laboratories: Murdoch University (WA, Australia), Doherty Institute (VIC, Australia)